Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications

The PI3K/AKT/mTOR pathway plays a crucial role in the development of leiomyosarcomas (LMSs). In this study, we tested the efficacy of dual PI3K/mTOR (BEZ235), PI3K (BKM120) and mTOR (everolimus) inhibitors in three human LMS cell lines. In vitro and in vivo studies using LMS cell lines showed that B...

Descripción completa

Detalles Bibliográficos
Autores principales: Fourneaux, Benjamin, Chaire, Vanessa, Lucchesi, Carlo, Karanian, Marie, Pineau, Raphael, Laroche-Clary, Audrey, Italiano, Antoine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352367/
https://www.ncbi.nlm.nih.gov/pubmed/28002802
http://dx.doi.org/10.18632/oncotarget.13987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352367/
https://www.ncbi.nlm.nih.gov/pubmed/28002802
http://dx.doi.org/10.18632/oncotarget.13987

Ejemplares similares